HIND

NASDAQ:HIND

Vyome Therapeutics Inc.

  • Stock
OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '24
revenue
8.01M
-
cost of revenue
2.95M
-
gross profit
5.06M
-
selling and marketing expenses
2.99M
-
general and administrative expenses
6.93M
-
selling general and administrative expenses
9.92M
-
research and development expenses
1.80M
-
other expenses
cost and expenses
15.73M
-
operating expenses
11.72M
-
interest expense
ebitda
-6.67M
-
operating income
-6.67M
-
depreciation and amortization
22K
-
total other income expenses net
637K
-
income before tax
-7.09M
-
income tax expense
39K
-
net income
-7.13M
-
weighted average shs out
20.62K
-
weighted average shs out dil
20.62K
-
eps
-345.74
-
epsdiluted
-345.74
-

All numbers in USD (except ratios and percentages)